PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,294,000 | -8.3% | 55,041 | -7.9% | 0.03% | -21.6% |
| Q3 2020 | $3,593,000 | -69.2% | 59,764 | -73.1% | 0.04% | -70.6% |
| Q2 2020 | $11,664,000 | +43.0% | 222,295 | -8.6% | 0.13% | +20.0% |
| Q1 2020 | $8,154,000 | -25.9% | 243,177 | +0.2% | 0.10% | -2.8% |
| Q4 2019 | $10,997,000 | +47.3% | 242,759 | +23.8% | 0.11% | +17.4% |
| Q3 2019 | $7,465,000 | -6.8% | 196,099 | +6.5% | 0.09% | -17.1% |
| Q2 2019 | $8,006,000 | +23.4% | 184,099 | +8.0% | 0.11% | +18.1% |
| Q1 2019 | $6,487,000 | +51.9% | 170,439 | +71.7% | 0.09% | +25.3% |
| Q4 2018 | $4,271,000 | +1464.5% | 99,289 | +1263.9% | 0.08% | +1400.0% |
| Q3 2017 | $273,000 | – | 7,280 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |